Penumbra is a healthcare company focused on therapies. Co. designs, develops, manufactures and markets products and has a portfolio that addresses various medical conditions. Co.'s neuro products include Penumbra System brand of products that provides a form of mechanical thrombectomy used by physicians to revascularize blood vessels that are blocked by clots in the intracranial vasculature. Co.'s vascular products include the Indigo System, which is designed for aspiration mechanical thrombectomy, utilizing the Penumbra System in ischemic stroke. Co.'s vascular products also include the Ruby Coil System, which consists of detachable coils that are designed for peripheral applications. The PEN average annual return since 2015 is shown above.
The Average Annual Return on the PEN average annual return since 2015 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether PEN average annual return since 2015 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the PEN average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|